REPUBLIC HEALTHCARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.088 HKD | 0.00% |
|
-7.37% | -4.35% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 64.25 | 44.92 | 26.14 | 39.41 | 17.66 | 9.699 |
| Enterprise Value (EV) 1 | 51.57 | 33.35 | 15.24 | 26.19 | 6.123 | -1.416 |
| P/E ratio | -78 x | 70.5 x | 399 x | -34.9 x | -12 x | -11.3 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 6.11 x | 3.33 x | 1.89 x | 2.82 x | 1.87 x | 0.94 x |
| EV / Revenue | 4.9 x | 2.47 x | 1.1 x | 1.87 x | 0.65 x | -0.14 x |
| EV / EBITDA | 28.5 x | 19.9 x | -47.9 x | -48.1 x | -9.65 x | 3.18 x |
| EV / FCF | 47.9 x | 16 x | -1,687 x | -22 x | -12.9 x | -1.46 x |
| FCF Yield | 2.09% | 6.26% | -0.06% | -4.54% | -7.76% | -68.6% |
| Price to Book | 5.11 x | 3.4 x | 1.97 x | 2.53 x | 1.25 x | 0.76 x |
| Nbr of stocks (in thousands) | 520,000 | 520,000 | 520,000 | 624,000 | 624,000 | 624,000 |
| Reference price 2 | 0.1236 | 0.0864 | 0.0503 | 0.0632 | 0.0283 | 0.0155 |
| Announcement Date | 3/28/19 | 3/30/20 | 3/22/21 | 3/23/22 | 3/23/23 | 3/28/24 |
1SGD in Million2SGD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 10.51 | 13.5 | 13.84 | 13.97 | 9.44 | 10.28 |
| EBITDA 1 | 1.808 | 1.679 | -0.3182 | -0.5444 | -0.6346 | -0.4457 |
| EBIT 1 | 1.392 | 1.17 | -0.7624 | -1.18 | -0.9225 | -0.6599 |
| Operating Margin | 13.24% | 8.67% | -5.51% | -8.44% | -9.77% | -6.42% |
| Earnings before Tax (EBT) 1 | -0.6438 | 1.099 | 0.1162 | -1.018 | -1.44 | -0.8282 |
| Net income 1 | -0.7306 | 0.6376 | 0.0659 | -0.9979 | -1.468 | -0.8551 |
| Net margin | -6.95% | 4.72% | 0.48% | -7.14% | -15.55% | -8.32% |
| EPS 2 | -0.001585 | 0.001226 | 0.000126 | -0.001811 | -0.002353 | -0.001370 |
| Free Cash Flow 1 | 1.076 | 2.089 | -0.009035 | -1.189 | -0.4751 | 0.9717 |
| FCF margin | 10.23% | 15.47% | -0.07% | -8.51% | -5.03% | 9.45% |
| FCF Conversion (EBITDA) | 59.48% | 124.39% | - | - | - | - |
| FCF Conversion (Net income) | - | 327.65% | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/28/19 | 3/30/20 | 3/22/21 | 3/23/22 | 3/23/23 | 3/28/24 |
1SGD in Million2SGD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 12.7 | 11.6 | 10.9 | 13.2 | 11.5 | 11.1 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 1.08 | 2.09 | -0.01 | -1.19 | -0.48 | 0.97 |
| ROE (net income / shareholders' equity) | -10.2% | 4.94% | 0.5% | -6.97% | -9.88% | -6.49% |
| ROA (Net income/ Total Assets) | 9.67% | 4.46% | -2.51% | -3.82% | -3.23% | -2.58% |
| Assets 1 | -7.552 | 14.3 | -2.626 | 26.13 | 45.44 | 33.14 |
| Book Value Per Share 2 | 0.0200 | 0.0300 | 0.0300 | 0.0200 | 0.0200 | 0.0200 |
| Cash Flow per Share 2 | 0.0200 | 0.0100 | 0.0300 | 0.0200 | 0.0200 | 0.0200 |
| Capex 1 | 0.42 | 0.6 | 0.54 | 0.62 | 0.42 | 0.08 |
| Capex / Sales | 3.98% | 4.44% | 3.89% | 4.43% | 4.48% | 0.8% |
| Announcement Date | 3/28/19 | 3/30/20 | 3/22/21 | 3/23/22 | 3/23/23 | 3/28/24 |
1SGD in Million2SGD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -4.35% | 7.02M | |
| -14.58% | 85.02B | |
| +15.05% | 82.37B | |
| +10.49% | 29.29B | |
| -10.17% | 17.21B | |
| -0.32% | 16.7B | |
| -31.05% | 11.8B | |
| +2.98% | 12.15B | |
| +31.86% | 12.12B | |
| -1.63% | 12.13B |
- Stock Market
- Equities
- 8357 Stock
- Financials Republic Healthcare Limited
